BJP CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lusznat, R. M.
Right arrow Articles by Nunn, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lusznat, R. M.
Right arrow Articles by Nunn, C. M.

The British Journal of Psychiatry 153: 198-204 (1988)
© 1988 The Royal College of Psychiatrists

Carbamazepine vs lithium in the treatment and prophylaxis of mania

RM Lusznat, DP Murphy and CM Nunn
Department of Psychiatry, Royal South Hants Hospital, Southampton, Hampshire.

Fifty-four acutely manic patients were allocated to treatment on a double-blind basis with either carbamazepine or lithium carbonate. The short-term effects of treatment were studied over a period of six weeks and the longer term, prophylactic, effects over a period of up to a year. Additional 'rescue' medication was allowed when clinically indicated. There was a high drop-out rate from the trial. Despite this, it appeared that valid comparisons between the two treatments could be made. No statistically significant differences were found, but carbamazepine appeared slightly less effective as a treatment for acute mania and more effective as a prophylactic treatment in this group of patients. Possible predictors of individual responsiveness to each treatment are discussed.


This article has been cited by other articles:


Home page
 Am. J. PsychiatryHome page
A. Cipriani, H. Pretty, K. Hawton, and J. R. Geddes
Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials
Am J Psychiatry, October 1, 2005; 162(10): 1805 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. S. Bauer and L. Mitchner
What Is a "Mood Stabilizer"? An Evidence-Based Response
Am J Psychiatry, January 1, 2004; 161(1): 3 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
A. C. Viguera, L. Tondo, and R. J. Baldessarini
Sex Differences in Response to Lithium Treatment
Am J Psychiatry, September 1, 2000; 157(9): 1509 - 1511.
[Abstract] [Full Text]

Home page
 J PsychopharmacolHome page
I. B. Kerr and D. Taylor
Acute disturbed or violent behaviour: principles of treatment
J Psychopharmacol, January 1, 1997; 11(3): 271 - 277.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
A. L. Malizia and P. K. Bridges
The management of treatment-resistant affective disorder: clinical perspectives
J Psychopharmacol, January 1, 1992; 6(2): 145 - 155.
[PDF]

Home page
 Journal of Pharmacy PracticeHome page
P. G. Dorson
Psychiatric Uses of Anticonvulsants
Journal of Pharmacy Practice, January 1, 1990; 3(4): 262 - 275.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1988 The Royal College of Psychiatrists.